Teladoc Health, Inc. (NYSE:TDOC – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday after Evercore ISI lowered their price target on the stock from $14.00 to $10.00. Evercore ISI currently has an in-line rating on the stock. Teladoc Health traded as low as $9.07 and last traded at $9.10, with a volume of 1340206 shares changing hands. The stock had previously closed at $9.26.
A number of other analysts have also recently weighed in on the stock. JPMorgan Chase & Co. decreased their price target on shares of Teladoc Health from $19.00 to $16.00 and set a “neutral” rating for the company in a research note on Tuesday, May 21st. Canaccord Genuity Group decreased their price target on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, April 26th. TD Cowen decreased their price target on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Stifel Nicolaus reduced their target price on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Finally, Bank of America lowered their price target on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a report on Tuesday, May 14th. Thirteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $17.97.
Insider Buying and Selling
In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at $440,240.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at $440,240.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Michael Willem Waters sold 5,793 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $73,513.17. Following the sale, the chief operating officer now owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,592 shares of company stock worth $397,064. Insiders own 0.95% of the company’s stock.
Hedge Funds Weigh In On Teladoc Health
Several institutional investors have recently modified their holdings of the company. Scotia Capital Inc. lifted its holdings in Teladoc Health by 123.5% in the third quarter. Scotia Capital Inc. now owns 17,742 shares of the health services provider’s stock worth $330,000 after purchasing an additional 9,803 shares during the period. Deutsche Bank AG lifted its holdings in Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock worth $5,598,000 after purchasing an additional 33,287 shares during the period. Sunbelt Securities Inc. lifted its holdings in Teladoc Health by 3.7% in the third quarter. Sunbelt Securities Inc. now owns 24,877 shares of the health services provider’s stock worth $462,000 after purchasing an additional 899 shares during the period. Ignite Planners LLC lifted its holdings in Teladoc Health by 10.6% in the fourth quarter. Ignite Planners LLC now owns 12,450 shares of the health services provider’s stock worth $273,000 after purchasing an additional 1,190 shares during the period. Finally, Westside Investment Management Inc. lifted its holdings in Teladoc Health by 46.2% in the fourth quarter. Westside Investment Management Inc. now owns 4,112 shares of the health services provider’s stock worth $89,000 after purchasing an additional 1,300 shares during the period. Institutional investors own 76.82% of the company’s stock.
Teladoc Health Stock Down 1.1 %
The firm has a market cap of $1.55 billion, a price-to-earnings ratio of -6.49 and a beta of 0.94. The firm’s fifty day moving average is $11.01 and its two-hundred day moving average is $15.14. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74.
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same period in the previous year, the company posted ($0.37) earnings per share. Teladoc Health’s revenue was up 2.7% compared to the same quarter last year. On average, sell-side analysts expect that Teladoc Health, Inc. will post -1.05 EPS for the current fiscal year.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.